May 11, 2026 01:08 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Big defence boost: India successfully tests advanced Agni MIRV missile | India, Singapore unite for tough action against terror and transnational crime | TVK crosses majority mark with VCK, IUML support | I bow before Bengal: PM Modi’s powerful gesture at Suvendu Adhikari’s oath goes viral | Bengal turns a new page: Suvendu Adhikari takes oath as CM amid massive NDA show of strength | Cloud over Tamil Nadu government formation as Governor asks Vijay to prove majority | 1 Year of Operation Sindoor: PM Modi says it showed India’s firm response to terror | ‘Larger conspiracy ahead of PM Modi’s visit’: BJP on killing of Suvendu Adhikari’s aide | ‘My car was on OLX for sale’: Siliguri owner says number plate used in Suvendu aide assassination may have been cloned online | ‘Pre-planned political assassination’: BJP’s Swapan Dasgupta on Suvendu aide’s killing
Narendra Modi
Narendra Modi Twitter page

Narendra Modi to interact with Gennova Biopharma, Biological E and Dr. Reddy’s teams

| @indiablooms | Nov 30, 2020, at 01:41 am

New Delhi: Prime Minister Narendra Modi will interact via video conferencing with Gennova Biopharma, Biological E and Dr. Reddy’s teams involved in developing a COVID-19 vaccine on Monday.

In a tweet, the Prime Minister said, "Tomorrow, on 30th November 2020, PM @narendramodi will interact, via video conferencing, with three teams that are involved in developing a COVID-19 vaccine. The teams he will interact with are from Gennova Biopharma, Biological E and Dr. Reddy’s."

Meanwhile, the Serum Institute will apply within two weeks for an emergency license to use the coronavirus vaccine being developed by the University of Oxford and pharma giant AstraZeneca, the Indian vaccine maker's chief Adar Poonawalla said on Saturday after a meeting with Prime Minister Narendra Modi.

"As of now, we don't have anything in writing with the government of India on how many doses they will purchase but the indication is that it would be 300-400 million doses by July 2021," he told reporters at a press conference.

"We are in the process of applying in the next two weeks for the emergency use," he added.

PM Modi on Saturday visited Zydus Biotech Park in Ahmedabad and Bharat Biotech facility in Hyderabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila as well as the vaccine candidate by Bharat Biotech.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.